Concepedia

Marta López‐Parra

ML

16

Publications

2.1K

Citations

16

H-Index

2002

Active since

Affiliations

Universitat de Barcelona(Current)

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Pfizer (United States)

Marta López‐Parra is an author at Universitat de Barcelona specializing in pharmacology, medicine, and oxidative stress.

Top concepts

Publications per year

2002–2011

16

Publications

16

Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins

Ana González‐Périz, Raquel Horrillo, Natàlia Ferré et al. · The FASEB Journal · 2009 · 553 citations · Full text

, , +20

Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts

Eva Morán‐Salvador, Marta López‐Parra, Verónica García‐Alonso et al. · The FASEB Journal · 2011 · 377 citations

Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA

Ana González‐Périz, Anna Planagumà, Karsten Gronert et al. · The FASEB Journal · 2006 · 222 citations

, , +16

5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity

Raquel Horrillo, Ana González‐Périz, Marcos Martínez‐Clemente et al. · The Journal of Immunology · 2010 · 148 citations

, , +20

The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation

Anna Planagumà, Joan Clària, Rosa Miquel et al. · The FASEB Journal · 2005 · 134 citations

, , +20

Rows per page

1–5 of 16